omeprazole has been researched along with tolterodine tartrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L; Böttiger, Y; Brynne, N; Hallén, B | 1 |
| Chen, A; Dmochowski, R; Gidwani, S; Gupta, S; MacDiarmid, S; Sathyan, G | 1 |
2 trial(s) available for omeprazole and tolterodine tartrate
| Article | Year |
|---|---|
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.
Topics: Adult; Anti-Ulcer Agents; Antihypertensive Agents; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cresols; Cross-Over Studies; Cytochromes; Debrisoquin; Drug Interactions; Humans; Male; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Polymorphism, Genetic; Tolterodine Tartrate; Urinary Bladder Diseases | 1999 |
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Benzhydryl Compounds; Cresols; Cross-Over Studies; Delayed-Action Preparations; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Tolterodine Tartrate | 2005 |